Toxicity of glutathione-binding metals: a review of targets and mechanisms
Pregnant or breastfeeding women (limited data)
Overexpression of IRP2 or MPP + treatment significantly enhances the binding of IRP2 to p53 in PC-12 cells, upregulates p53 levels, downregulates SLC7A11 expression, and increases arachidonate 12-Lipoxygenase (ALOX12) expression, thereby promoting ferroptosis and amino acid antioxidant system disruptions, elevating MDA levels, and inducing PC-12 cell damage
Because ingredient transparency plays such a large role in consumer trust, ProHealth Longevity BPC-157 is often compared against alternatives that either disclose less detail or rely on proprietary blends
See OVERDOSAGE for toxicity information
Efficacy and safety of L-carnitine treatment for chronic heart failure: a meta-analysis of randomized controlled trials